<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02947828</url>
  </required_header>
  <id_info>
    <org_study_id>IDNC-DD2-NP</org_study_id>
    <nct_id>NCT02947828</nct_id>
  </id_info>
  <brief_title>Polyneuropathy in Diabetes Mellitus Type 2</brief_title>
  <official_title>Polyneuropathy in Diabetes Mellitus Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Pain Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Pain Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a population-based study of type 2 diabetes patients with and without neuropathy
      recruited from the Danish National Type 2 Diabetes cohort (DD2).

      Perspective: The study will identify risk factors for developing diabetic polyneuropathy and
      painful diabetic polyneuropathy and provide information on the underlying mechanisms, which
      will hopefully contribute to significant improvements in the treatment and prevention of
      diabetic polyneuropathy in future.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetic polyneuropathy is one of the most common long-term complications of diabetes.
      Neuronal hyperexcitability is thought to be a key factor in the development of neuropathic
      pain.

      The overall purpose of this study is to evaluate the prevalence and underlying mechanisms of
      diabetic polyneuropathy and painful diabetic polyneuropathy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of diabetic polyneuropathy</measure>
    <time_frame>5 hours</time_frame>
    <description>For case definition of neuropathy, Tesfaye et al. 2010 will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of painful diabetic polyneuropathy</measure>
    <time_frame>5 hours</time_frame>
    <description>Neuropathic pain grading system. Finnerup et al. 2016 will be used.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Diabetes Mellitus Type 2 Without Complication</condition>
  <condition>Polyneuropathies, Diabetic</condition>
  <condition>Diabetes Complications</condition>
  <condition>Diabetic Peripheral Neuropathy</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>T2D patients</arm_group_label>
    <description>600 type 2 diabetes (T2D) patients recruited from the DD2 cohort</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gender- and age-matched healthy controls</arm_group_label>
    <description>100 healthy subjects</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Skin punch biopsies and blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Type 2 diabetes patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria T2D patients:

          -  Clinical diagnosis of type 2 diabetes

        Exclusion Criteria:

          -  Pregnancy

          -  Poor or no Danish language skills

          -  Insufficient mental capacity to provide informed consent or complete questionnaires

        Additional criteria for healthy controls:

          -  Any neurological or psychiatric disorder

          -  Chronic pain

          -  Severe illness

          -  Pain treatment 3 days before the examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sif Gylfadottir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University and Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sif Gylfadottir, MD</last_name>
    <phone>+45 7846 3287</phone>
    <email>sifgyl@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nanna B. Finnerup, MD, DMSc.</last_name>
    <phone>+45 78464230</phone>
    <email>finnerup@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Danish Pain Research Center, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sif Gylfadottir, MD</last_name>
      <phone>+45 7846 3287</phone>
      <email>sifgyl@clin.au.dk</email>
    </contact>
    <contact_backup>
      <last_name>Nanna B. Finnerup, MD, DrMedSc</last_name>
      <phone>+45 7846 4230</phone>
      <email>finnerup@clin.au.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Sif Gylfadottir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303. Review. Erratum in: Diabetes Care. 2010 Dec;33(12):2725.</citation>
    <PMID>20876709</PMID>
  </reference>
  <reference>
    <citation>Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016 Aug;157(8):1599-606. doi: 10.1097/j.pain.0000000000000492. Review.</citation>
    <PMID>27115670</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2016</study_first_submitted>
  <study_first_submitted_qc>October 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Polyneuropathies, Diabetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
    <mesh_term>Diabetes Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data is shared among collaborators.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

